BT Zhai, H Tian, J Sun, JB Zou, XF Zhang… - Journal of translational …, 2022 - Springer
Urokinase-type plasminogen activator receptor (uPAR) is an attractive target for the
treatment of cancer, because it is expressed at low levels in healthy tissues but at high levels …